Patients & Families

Company Overview

Renova Therapeutics is dedicated to creating definitive one-time gene therapy treatments for some of the world’s most common and debilitating chronic diseases: congestive heart failure and type 2 diabetes. We’re also developing peptide therapies to ease suffering.
About Gene Therapy

Imagine a new era of medicine, in which a one-time treatment – not a weekly infusion, not an invasive procedure – can restore your health or the health of a loved one. Gene therapy is on the brink of making this possible.
Our Lead Product (RT-100)

Renova Therapeutics is working on a single-dose treatment for congestive heart failure. RT-100 has the potential to help improve heart function by enabling the heart to pump more effectively – so you or your loved one can live life free of the burden of CHF.
Clinical Trial Participation

With funding and support from the National Institutes of Health’s National Heart, Lung, and Blood Institute, Renova Therapeutics completed a Phase 2 clinical trial of RT-100 for congestive heart failure. Find out about future trials for CHF as well as type 2 diabetes here.